Open Label Extension
Public ClinicalTrials.gov record NCT00172120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 18-month, Open-label Extension Study of Once-daily ALX1-11 for the Treatment of Postmenopausal Women With Osteoporosis (TRES)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
TRES will evaluate the effects of continued ALX1-11 treatment on the safety and efficacy variables assessed in the OLE study for a maximum treatment duration of 36 months in OLES and TRES combined.
Study identification
- NCT ID
- NCT00172120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 9, 2005
- Primary completion
- Oct 26, 2006
- Completion
- Oct 26, 2006
- Last update posted
- May 16, 2021
2005 – 2006
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 'Osteoporosis Medical Center | Beverly Hills | California | 90211 | — |
| 'The University of Chicago | Chicago | Illinois | 60637 | — |
| 'Michigan Bone & Mineral Clinic | Detroit | Michigan | 48236 | — |
| 'Odyssey Research Services | Bismarck | North Dakota | 58501 | — |
| Michael J. Lillestol | Fargo | North Dakota | 58103 | — |
| 'Odyssey Research Services | Minot | North Dakota | 58701 | — |
| 'Rapid City Medical Center | Rapid City | South Dakota | 57701 | — |
| 'Brown Clinic | Watertown | South Dakota | 57201 | — |
| 'Fletcher Allan Health Center, UHC Campus 1 | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00172120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00172120 live on ClinicalTrials.gov.